← Back to Search

Oxygen and Fluid Pressure Measurements for Cervical Cancer

Phase 2
Waitlist Available
Led By Anthony Fyles, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is measuring oxygen and fluid pressure in the cervix of cancer patients to see if it affects treatment options.

Who is the study for?
This trial is for individuals newly diagnosed with cervical cancer, specifically those with tumors 3 cm or larger. Participants must be undergoing an examination under anesthesia for staging and must provide informed consent to partake in the study.
What is being tested?
The study aims to measure oxygen levels and interstitial fluid pressure inside cervical cancer tumors. These measurements are taken before any treatment starts, as they may affect how well radiotherapy and other treatments work.
What are the potential side effects?
Since this trial involves measurement procedures rather than drug interventions, side effects are related to the risks of anesthesia and potential discomfort from the measuring process itself.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pre-treatment tumour oxygen measurements (under anesthesia)Experimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,531 Previous Clinical Trials
504,022 Total Patients Enrolled
Canadian Cancer Trials GroupNETWORK
132 Previous Clinical Trials
69,567 Total Patients Enrolled
Princess Margaret Hospital, CanadaOTHER
120 Previous Clinical Trials
39,652 Total Patients Enrolled
Anthony Fyles, MDPrincipal InvestigatorPrincess Margaret Hospital, Canada
7 Previous Clinical Trials
964 Total Patients Enrolled

Media Library

Pre-treatment tumour oxygen measurements (under anesthesia) Clinical Trial Eligibility Overview. Trial Name: NCT00188539 — Phase 2
Cervical Cancer Research Study Groups: Pre-treatment tumour oxygen measurements (under anesthesia)
Cervical Cancer Clinical Trial 2023: Pre-treatment tumour oxygen measurements (under anesthesia) Highlights & Side Effects. Trial Name: NCT00188539 — Phase 2
Pre-treatment tumour oxygen measurements (under anesthesia) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00188539 — Phase 2
~10 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top